clinical potential of trastuzumab biosimilar ctp6
Published 7 years ago • 58 plays • Length 4:55Download video MP4
Download video MP3
Similar videos
-
3:57
introduction of the biosimilar trastuzumab and its impact on patients and services
-
1:47
results of a phase iii trial on ct-p6, a trastuzumab biosimilar candidate, in early breast cancer
-
1:40
dr. esteva on clinical trial design of trastuzumab biosimilar in her2 breast cancer
-
11:04
shorther trastuzumab treatment of her2 breast cancer: 9 weeks v 1 year
-
3:38
biosimilar trastuzumab
-
3:18
trial of proposed trastuzumab biosimilar, myl-1401o vs herceptin
-
0:32
the potential of biosimilars in cancer treatment
-
2:07
dr. esteva on the trastuzumab biosimilar candidate ct-p6 in her2 breast cancer
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
1:53
dr. rugo discusses a comparative review of trastuzumab biosimilars
-
12:12
breast cancer treatment - trastuzumab biosimilars
-
2:33
positive results for trastuzumab biosimilar ct-p6 in her2 early breast cancer
-
0:51
dr. jhaveri on the use of trastuzumab biosimilars in breast cancer
-
4:35
a multi-histology basket trial of ado-trastuzumab emtansine in patients with her2 amplified cancers
-
2:43
margetuximab for the treatment of her2-positive breast cancer
-
1:41
dr. pegram on the development of trastuzumab biosimilars
-
1:00
dr. dang on the significance of the myl-1401o biosimilar in her2-positive metastatic breast cancer
-
1:43
dr. rugo discusses the equivalency of trastuzumab biosimilars
-
0:35
termination of trastuzumab in her2-positive metastatic breast cancer patients who rec... | rtcl.tv